19 Recruiting Metastatic Breast Cancer Phase 1 Clinical Trials
Active phase 1 studies for metastatic breast cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Metastatic Breast Cancer studiesPhase 1 Studies for Metastatic Breast Cancer
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
📍 Research Site — Commack, New York
View Study & Checklist ➔A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
📍 Research Site — Fort Myers, Florida
View Study & Checklist ➔Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
📍 Research Facility — Phoenix, Arizona
View Study & Checklist ➔Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
📍 Ashley Donihee — Charlottesville, Virginia
View Study & Checklist ➔A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
📍 Jacinto Convit World Organization, Inc. — Pompano Beach, Florida
View Study & Checklist ➔A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
📍 Huntsman Cancer Institute — Salt Lake City, Utah
View Study & Checklist ➔Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
📍 The Oncology Institute of Hope and Innovation — Cerritos, California
View Study & Checklist ➔A Study of HLD-0117 in Patients With Metastatic Breast Cancer
📍 Yale University School Of Medicine — New Haven, Connecticut
View Study & Checklist ➔Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
📍 Dana-Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
📍 Weill Cornell Medicine — New York, New York
View Study & Checklist ➔A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
📍 Memorial Sloan Kettering at Basking Ridge (All protocol activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
📍 Dartmouth Cancer Center — Lebanon, New Hampshire
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study of Pembrolizumab and Cryoablation in People With Breast Cancer
📍 Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔